Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

XORTX Therapeutics Inc. - Common Stock (NQ:XRTX)

0.9560 +0.0560 (+6.22%)
Streaming Delayed Price Updated: 10:55 AM EDT, Apr 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,686
Open 0.9500
Bid (Size) 0.9200 (6)
Ask (Size) 0.9650 (10)
Prev. Close 0.9000
Today's Range 0.9100 - 0.9560
52wk Range 0.8200 - 3.920
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's going on in today's after hours session
As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
Why MongoDB Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga

Performance

YTD
-18.3%
-18.3%
1 Month
+1.6%
+1.6%
3 Month
-15.4%
-15.4%
6 Month
-38.3%
-38.3%
1 Year
-73.7%
-73.7%

More News

Read More
Nasdaq Surges Over 1%; Best Buy Posts Upbeat Earnings
Via Benzinga
Dow Jumps Over 100 Points; Nvidia Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
XRTX Stock Earnings: XORTX Therapeutics Reported Results for Q2 2024
Via InvestorPlace
XRTX Stock Earnings: XORTX Therapeutics Reported Results for Q1 2024
Via InvestorPlace
XORTX: A Year of Milestones and Strategic Advancements as it Readies for a Registration Clinical Trial
Via Get News
Topics Intellectual Property
Exposures Intellectual Property Product Safety
XORTX: A Year of Milestones and Strategic Advancements as it Readies for a Registration Clinical Trial
Via News Direct
Topics Intellectual Property
Exposures Intellectual Property Product Safety
XORTX: A Year of Milestones and Strategic Advancements as it Readies for a Registration Clinical Trial
Via TheNewswire.com
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Logitech International Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Asbury Automotive Group Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Okta Stock Continues to Fall Following Security Breach
Via InvestorPlace
Topics Data Breach
Exposures Information Security
Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Dow Falls Over 100 Points; Chicago Fed National Activity Index Increases In September
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Is Xortx Therapeutics (XRTX) Stock Down 27% Today?
Via InvestorPlace
Why Troika Media Group Shares Are Trading Lower By Over 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
What's Going On With Xortx Therapeautics Stock?
Via Benzinga
Why Adial Pharmaceuticals Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga

Frequently Asked Questions

Is XORTX Therapeutics Inc. - Common Stock publicly traded?
Yes, XORTX Therapeutics Inc. - Common Stock is publicly traded.
What exchange does XORTX Therapeutics Inc. - Common Stock trade on?
XORTX Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for XORTX Therapeutics Inc. - Common Stock?
The ticker symbol for XORTX Therapeutics Inc. - Common Stock is XRTX on the Nasdaq Stock Market
What is the current price of XORTX Therapeutics Inc. - Common Stock?
The current price of XORTX Therapeutics Inc. - Common Stock is 0.9560
When was XORTX Therapeutics Inc. - Common Stock last traded?
The last trade of XORTX Therapeutics Inc. - Common Stock was at 04/02/25 10:55 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.